Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04549493 · ClinicalTrials.gov registry record · NA
Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy
A NA study of PTSD, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT04549493: Completed NA study of PTSD, sponsored by University of Central Florida.
NCT04549493 is a NA study of PTSD that has completed, run by University of Central Florida. The registered enrollment target is 134 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04549493, a NA study of PTSD, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this requirement is to identify an effective exposure psychotherapy paradigm for the treatment of Post-Traumatic Stress Disorder (PTSD) in active duty service members and veterans by comparing different exposure psychotherapy modalities. The long-term goal of exposure psychotherapy is to improve the mental health of U.S. service members and veterans with military-related PTSD. Recovery from PTSD will reduce the economic burden not only for those persons experiencing PTSD, but also for the health care system and society as a whole (Galovski \& Lyons, 2004).
Primary Outcome
PTSD symptoms rating scale (severity and frequency) administered by blinded clinician
Conditions Studied
Interventions
- BEHAVIORAL Exposure Therapy
Study Locations (1)
Florida
- UCF RESTORES, University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
What the finished NCT04549493 record still lists
NCT04549493 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (55% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Exposure Therapy is the first listed.
NCT04549493 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04549493 about?
NCT04549493 is a clinical study titled "Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy". The purpose of this requirement is to identify an effective exposure psychotherapy paradigm for the treatment of Post-Traumatic Stress Disorder (PTSD) in active duty service members and veterans by comparing different exposure psychotherapy modalities. The long-term goal of exposure psychotherapy is...
What is the current status of trial NCT04549493?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2020-02-12. Estimated completion is 2024-05-01.
What conditions does trial NCT04549493 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT04549493?
The interventions under investigation include: Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04549493?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04549493 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04549493's enrollment target sits among peer trials
134 49th of 154 higher than 106 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI